Trial intelligence / Profile preview

Stinging Potential of SPF 50 Sunscreen Formulas in Human Eyes

NCT02802917Completed

Sponsor
Bayer
Start
May 2015
Primary completion
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of BAY 987516 in sunburn (4 arms), sponsored by Bayer. Primary endpoints: Subjective discomfort at 10 days, Objective lacrimation at 10 days and 2 more. Started May 2015; status: completed.

02

Drugs

BAY 987516
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02802917.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02802917.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call